Thermo Fisher (TMO) Is Turning Innovation Into Recurring Revenue. Can Margins Follow?
On September 23, Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 2,915,715 | $1,461,823,432 | +3% | 0.44% |
| 2. | Unisphere Establishment Hani Lazkani (Ceo) | 2,060,000 | $1,032,801,600 | 8.79% | |
| 3. | Viking Global Andreas Halvorsen | 1,937,415 | $971,342,384 | +17% | 2.77% |
| 4. | Farallon Capital Thomas Steyer | 1,049,185 | $526,019,392 | +20% | 2.43% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,007,394 | $505,067,056 | +59% | 0.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $535.93 | 4 | $2,143.73 | 14,268 | 2024-12-09 | Filing | |
| $555.89 | 16 | $8,894.24 | 14,264 | 2024-11-07 | Filing | |
| $526.15 | 4 | $2,104.60 | 13,101 | 2023-06-26 | Filing | |
| $134.16 | 1,000 | $134,160.00 | 14,636 | 2015-12-11 | Filing | |
| $45.84 | 36 | $1,650.24 | 25,914 | 2010-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $614.38 | 3,733 | $2,293,480.54 | 23,216 | 2026-08-31 | Filing | |
| $614.38 | 400 | $245,752.00 | 23,216 | 2026-08-31 | Filing | |
| $628.74 | 62 | $38,981.88 | 123,925 | 2026-08-24 | Filing | |
| $628.01 | 79 | $49,612.79 | 123,987 | 2026-08-24 | Filing | |
| $626.59 | 33 | $20,677.47 | 124,066 | 2026-08-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 85,793 | $57,914,988 | 0.97% | |
| 2. | 6,191 | $4,179,234 | 0.39% | |
| 3. | 4,062 | $2,742,297 | 0.6% | |
| 4. | 2,533 | $1,709,901 | 0.26% | |
| 5. | 1,165 | $786,433 | 0.07% |
News See All
10 Best Healthcare Stocks to Buy According to Hedge Funds
Healthcare has rarely been short of investment opportunities, but deciding where to look has become more complicated.
Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?
Gilead Sciences, Inc. (NASDAQ:GILD) and Thermo Fisher Scientific Inc. (NYSE:TMO) are benefiting from two very different sources of growth.
Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?
Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, but their recoveries look very different.
Dodge and Cox's Bullish Stance on Thermo Fisher Scientific (TMO)
Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. You can download a copy of the letter here. U.S.
Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation - But Is He Right?
Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)'s shares have done well in September and are up by more than 8% since the 10th.
Thermo Fisher Scientific (TMO) is Positioned for Resurgence
Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S.
Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?
Turnarounds in the healthcare sector do not all look the same.
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions.
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?
Healthcare investors looking for long-term growth don't always have to choose between fast-growing companies and defensive businesses.